Medeiros, who joins the group from AVI BioPharma, will join the executive leadership team and be responsible for extending and expanding areas for growth.
Based in the UK, Mundipharma is a network of companies across 32 European countries, including Napp in the UK.
Medeiros was previously Senior VP and Chief Business Officer at AVI BioPharma, a specialist in RNA-based drugs for rare diseases.
Over 19 years in the biopharmaceutical industry, Medeiros has also been VP of Global Licensing and Strategic Alliances for Schering-Plough and held several roles in sales and marketing at Merck & Co.
His experience includes licensing and strategic partnering initiatives in specialist therapy areas.
Antony Mattessich, Regional Director, Mundipharma Europe, said: “Paul’s deep experience and network in the pharma industry, combined with his entrepreneurial mind-set and nuanced understanding of the business, will be essential for Mundipharma’s continued growth.”